Seeann Solution
Patient-specific instrument (PSI) manufacturing using 3D printing for medical applications.
- CEO / Founder
- Anna Seo
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $100K
- Latest Round
- Seed
- Key Investors
- G-Leaders, CNT Tech, Demo Day Program, CGBIO, Biig Wave, CNTTECH and 5 more
Technology & Products
Key Products
Reconeasy software (DICOM-to-3D reconstruction), patient-specific instruments (PSI), and surgical guides for orthopedic and veterinary procedures.
Technological Advantage
CLAIMED: Semi-automatic anatomy segmentation and intuitive 3D volume editing algorithms in Reconeasy software reduce planning time vs. manual DICOM workflows. VERIFIED: Three copyrighted software titles (Reconeasy 3D, Reconeasy Ortho, Reconeasy Collabo) registered with Korean IP authorities; Class II approval for surgical guidance and Class III approvals for animal bone plates and screws confirmed by company milestone disclosures; Reconeasy cited in peer-reviewed PMC literature (TPLO osteotomy study) confirming clinical adoption. Advantage is partially defensible via software copyright and regulatory clearances, though the underlying 3D printing process itself is replicable.
Differentiation
Value Proposition
Enables surgeons to plan and execute complex orthopedic and veterinary procedures using patient-specific instruments (PSI) and surgical guides manufactured via 3D printing, combined with proprietary DICOM-to-3D reconstruction software (Reconeasy), reducing surgical risk through custom-fit, pre-operative simulation-validated devices cleared as Class II/III medical devices in Korea.
How They Differentiate
Versus Materialise: SEEANN offers a domestically produced, Korean-regulatory-cleared end-to-end service at likely lower cost and faster turnaround for Korean hospital clients, whereas Materialise operates as a global platform with higher pricing and longer import logistics. Versus 3D Systems VSP: SEEANN extends into veterinary orthopedics (custom animal bone plates/screws) - a niche not addressed by major global PSI vendors - creating an additional revenue stream and beachhead market. SEEANN's integrated Reconeasy software suite removes the need for third-party planning tools, tightening the service bundle.
Market & Competition
Target Customers
Orthopedic and veterinary surgeons, hospitals and surgical centers requiring patient-specific instruments, biomedical engineers involved in surgical planning.
Industry Verticals
Medical
Competitors
Materialise, 3D Systems VSP
Growth & Milestones
Major Milestones
Founded 2017 (Seeann Solution Co., Ltd. established); registered as 3D printing service company; 3 software copyrights registered (Reconeasy 3D, Reconeasy Ortho, Reconeasy Collabo); Class II medical device approval for surgical guidance (human); Class II and Class III approvals for animal custom plates and screws; launch of surgical guidance supply contracts with hospitals; venture business certification (renewed); selected for TIPS program; NIPA 3D printing application excellence award; I-STAR FUNDing UP CONTEST excellence award (ICN); corporate affiliated research institute approved; Reconeasy cited in PMC-indexed peer-reviewed clinical study.
Notable Customers
Hospitals in Korea (surgical guidance supply contracts launched per company milestone disclosure); veterinary clinics and animal hospitals using custom 3D-printed bone plates and screws.